According to Future Market Insights, the evolution of the market is being directed by factors such as the emphasis placed by healthcare providers on reproducible component alignment, quantifiable functional results, and throughput discipline in large volumes of arthroplasty. There is now recognition of robotic enablement in the form of procedural infrastructure that links pre-operative planning, intra-operative execution, and post-operative verification, rather than viewing robotic enablement as optional capital equipment. This is being compounded by healthcare systems looking to reduce surgeon-to-surgeon variability, enhance pathway standardization, and minimize revisions with the ability to control execution accuracy as well as soft tissue balancing.